#ClinicalPearls #rheumatoid #arthritis is changing. Less extra articulation and less mortality except ILD. Legacy pts exposed to ASA high dose, NSAIDs and injectable gold. We still see it rarely. @RheumNow #EULAR2023 @eular_org https://t.co/sC8vZkjO2x https://t.co/BFdpubei4u